| Name | Title | Contact Details |
|---|
EFCO Products, Inc. is a global leader in creating and distributing innovative savory sauces, bakery fillings, bakery mixes, bakery concentrates, beverage bases and syrups, sauces and spreads, fruit toppings and specialty toppings that have made us the “go to” company for Corporate Chefs, Bakery Professionals, Marketing Leaders and Supply Chain Buyers. Founded in 1903, EFCO Products prides itself in providing premium off-the-shelf and custom prepared products with the finest ingredients. We are a family-owned company that treats each of our employees and customers like family. EFCO`s sweet and savory products are enjoyed by millions daily. As we continue to expand our product line, we will always remain true to our core values of quality, an unrelenting standard for excellence and exceeding customers` expectations.
Creating innovative product solutions that showcase authentic worldly flavors. We service every channel by delivering flavors from around the globe.
Feast Kitchens products were created by Feast From the East, a restaurant based in Los Angeles, California that first opened its doors back in 1981 as a hole in the wall Chinese and Japanese take-out restaurant with only two tables.
Brewbike exists to empower young people. We partner with students to launch innovative coffee concepts, develop entrepreneurial skills and energize their communities.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.